My interests

Receive our interest that have beensaved and send them to one of your contacts by entering a valid email address :

Sign up to our news and newsletters

Sign me up to these newsletters:

  • Capital Market

  • Civil Business Law

  • Civil Liability

  • Competition-Distribution Law

  • Employment Law

  • IARD (Fire, Accidents and Multi-Risk) Insurance

  • Insurance/Construction

  • Medical Liability

  • Public Law

Sign me up to these Brèves:

  • Brèves d'actualités

  • News flashes

Confirm

Thank you, you are registered

(0)

Associates

Ornella
  • Paris

Bianchi
  • Paris

Languages : French, English, Chinese

Paris Bar (2019)
Associate at Racine since 2020

Contact :

Tel : +33 (0)1 44 82 43 00

Add to my interests

Career

DLA Piper

AXA Investment Managers

Education

Master’s degree in International Management and Law, HEC Paris (2015 – 2016)

Master’s degree in Business Law, Université Paris 1 Panthéon-Sorbonne (2013 – 2014)

Master’s in Law and International Relations, Université de Fudan, Shanghai (2012 – 2014)

Diploma in “Common Law”, Université de Cork (2011 – 2012)

 

Experiences

 

 

 

Team's
recongnitions

Rankings

  • Magazine des Affaires - 2024: Private Equity – LBO
  • Magazine des Affaires - 2024: Corporate M&A
  • Magazine des Affaires - 2024: M&A : Structuring fiscal en LBO
  • Legal 500 - 2022: Mergers & Acquisitions
  • Chambers - 2022: M&A

Awards

  • 2023: Sommet du Droit

    LBO, lower mid & small cap transactions

  • 2015: Trophées du droit et du contentieux

    Mergers & Acquisitions – small- and mid-cap: Silver trophy

    Entrepreneurial firm over five years old: Gold trophy

  • 2018: Top Legal

    Top Legal

  • 2018: Trophées du droit et du contentieux

    Mergers & Acquisitions : Small & Mid Cap: Gold trophy

The team

01 / 22
View all our teams

News and latest publications

Press releases

10/06/21

Racine advises Docapost on its acquisition of a stake in Adobis Group

The full version of this article is in French Click below to read it
Read more

Press releases

19/04/21

Racine advises Onward Therapeutics on its investment to Biomunex and EMERCell, two biotech start-ups

Racine advises Onward Therapeutics, a Swiss biotechnology company active in the field of oncology, on its acquisition of minority stakes in Biomunex and EMERCell. These transactions represent Onward Therapeutics’ first two strategic investments in France. Headed by the successful biotech...
Read more
View all

Receive our information

Confirm